跳至主要内容
临床试验/NCT07063108
NCT07063108尚未招募4 期

Efficacy and Safety of S-ketamine Hydrochloride Injection in Elderly Patients Undergoing Elective Non-cardiac Surgery: a Multicenter, Randomized, Placebo Controlled Clinical Trials(ESSENCE)

Chinese PLA General Hospital0 个研究点目标入组 276 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
276
主要终点
NRS pain score at the 24th hour after operation.

研究概览

简要总结

This national, multi-center, randomized controlled study, through the study of intravenous injection of estaketamine in elderly patients undergoing surgery, is expected to explore whether estaketamine can improve the acute postoperative pain of elderly patients undergoing surgery and reduce the incidence of postoperative depression and delirium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged > 65 years old, no gender limitation;
  • patients undergoing elective thoracic, abdominal and orthopedic surgery;
  • ASA score is Class I-Class ~III;
  • 18 kg/ m2<BMI<30kg/m2;
  • The operation time is estimated to be 2 h-4 h;
  • Know clearly and voluntarily participate in this study, and sign informed consent form by oneself.

排除标准

  • patients with severe chronic pain;
  • Anemia or thrombocytopenia, Hb < 90 g/L, PLT < 80 × 109/L;
  • Severe liver dysfunction, AST and/or ALT≥2.5×ULN, and TBIL ≥ 1.5 × ULN;
  • severe renal dysfunction, blood creatinine is greater than the upper limit of normal;
  • Severe cardiovascular history (such as myocardial ischemia, heart failure and arrhythmia); Angina pectoris (unstable angina pectoris) caused by insufficient blood supply to the coronary vessels of the heart, or myocardial infarction in the past 6 months; QT interval prolongation (≥460ms in males and ≥ 470 ms in females);
  • Patients with hypertension whose blood pressure is not satisfactorily controlled by antihypertensive drugs (systolic blood pressure in sitting position during screening stage ≥180 mmHg, and/or diastolic blood pressure during screening stage ≥ 100 mmHg);
  • Patients with craniocerebral injury, possible intracranial hypertension, cerebral aneurysm, cerebrovascular accident history and central nervous system disease history;
  • patients with glaucoma or serious increase in intraocular pressure risk;
  • patients with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.) and drug history and cognitive dysfunction; History of cognitive psychiatric disorders such as postoperative delirium; Pregnant or lactating women;
  • high risk surgery, is expected to enter the ICU after surgery;
  • to moxa ketamine hydrochloride and its drug components allergy or taboo;
  • Being a subject and having participated in clinical trials for other drugs in the past three months;
  • There is communication disorder;
  • Patients considered by the investigator to be ineligible for participation in this trial.

研究组 & 干预措施

Test group (esketamine injection)

Experimental

Test group (esketamine injection group): Intravenous infusion of esketamine: after induction, a single dose of 0.25 mg/kg before skin incision,and continuous 0.125 mg/kg/h until 30 min before surgery was stopped.

干预措施: Esketamine hydrochloride (Drug)

Control group (placebo: saline)

Placebo Comparator

Control group (placebo: saline): after induction, a single intravenous infusion of an equal amount of 0.9% saline before skin incision, followed by a continuous infusion at the same rate as the test group until 30 min before surgery was stopped.

干预措施: Saline (Drug)

结局指标

主要结局

NRS pain score at the 24th hour after operation.

时间窗: 24th hour after operation

NRS pain score at the 24th hour after operation.

次要结局

  • NRS pain scores at the 2nd hour, 48th hour and 72nd hour after operation.(the 2nd hour, 48th hour and 72nd hour after operation.)
  • The incidence of delirium within 72 hours after operation(72 hours after operation)
  • The evaluation of APS-POQ-R questionnaire at 24 hours, 48 hours and 72 hours after operation.(24 hours, 48 hours and 72 hours after operation.)
  • The scores of Montgomery Depression Scale at 24th hour, 48th hour and 72nd hour after operation.(24th hour, 48th hour and 72nd hour after operation.)
  • The consumption of anesthetic and analgesic drugs during and within 72 hours after operation.(during and within 72 hours after operation.)
  • The score of GAD-7 anxiety scale 72 hours after operation. The incidence of delirium within 72 hours after operation(72 hours after operation)
  • The incidence of adverse events during and within 72 hours after operation.(72 hours after operation.)

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Weidong Mi

Director of Anesthesia Department

Chinese PLA General Hospital

相似试验